The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.97.5.1007

1. A two-year follow-up study of 1039 cases of dementia præcox treated by the pharmacological shock method in the New York state hospitals is presented and discussed.

2. It is recommended that statistical compilations include all the factors that seem to be related to the outcome of treatment.

3. Uniform recording of the treatment based upon the neurological signs of the insulin effect is advocated.

4. Uniform criteria for the interpretation of the results of treatment should be established.

5. The value of metrazol as a part of the pharmacological shock treatment is discussed.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.